This is in line with a previous study on hepatocellular carcinoma that observed the macrophage CD39 and HCC cell CD73 synergistically activate ATP–adenosine pathway to directly impair antitumor immunity [34]. The gene discussed is ENTPD1; the disease is hepatocellular carcinoma.